AR052784A1 - Metodos para atrapar, inactivar y eliminar infecciones virales mediante la administracion de composiciones para el tracto respiratorio - Google Patents

Metodos para atrapar, inactivar y eliminar infecciones virales mediante la administracion de composiciones para el tracto respiratorio

Info

Publication number
AR052784A1
AR052784A1 ARP050104576A ARP050104576A AR052784A1 AR 052784 A1 AR052784 A1 AR 052784A1 AR P050104576 A ARP050104576 A AR P050104576A AR P050104576 A ARP050104576 A AR P050104576A AR 052784 A1 AR052784 A1 AR 052784A1
Authority
AR
Argentina
Prior art keywords
polymers
agent
homopolymers
mixtures
acrylic acid
Prior art date
Application number
ARP050104576A
Other languages
English (en)
Inventor
Paul John Rennie
Jayant Ekanth Khanolkar
George William Jessen
Original Assignee
Procter & Gamble
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter & Gamble filed Critical Procter & Gamble
Publication of AR052784A1 publication Critical patent/AR052784A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals
    • A61K31/315—Zinc compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/765—Polymers containing oxygen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/30—Zinc; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • D—TEXTILES; PAPER
    • D21—PAPER-MAKING; PRODUCTION OF CELLULOSE
    • D21H—PULP COMPOSITIONS; PREPARATION THEREOF NOT COVERED BY SUBCLASSES D21C OR D21D; IMPREGNATING OR COATING OF PAPER; TREATMENT OF FINISHED PAPER NOT COVERED BY CLASS B31 OR SUBCLASS D21G; PAPER NOT OTHERWISE PROVIDED FOR
    • D21H21/00—Non-fibrous material added to the pulp, characterised by its function, form or properties; Paper-impregnating or coating material, characterised by its function, form or properties
    • D21H21/14—Non-fibrous material added to the pulp, characterised by its function, form or properties; Paper-impregnating or coating material, characterised by its function, form or properties characterised by function or properties in or on the paper
    • D21H21/36—Biocidal agents, e.g. fungicidal, bactericidal, insecticidal agents
    • D—TEXTILES; PAPER
    • D21—PAPER-MAKING; PRODUCTION OF CELLULOSE
    • D21H—PULP COMPOSITIONS; PREPARATION THEREOF NOT COVERED BY SUBCLASSES D21C OR D21D; IMPREGNATING OR COATING OF PAPER; TREATMENT OF FINISHED PAPER NOT COVERED BY CLASS B31 OR SUBCLASS D21G; PAPER NOT OTHERWISE PROVIDED FOR
    • D21H27/00—Special paper not otherwise provided for, e.g. made by multi-step processes
    • D21H27/30—Multi-ply
    • D21H27/32—Multi-ply with materials applied between the sheets

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Pest Control & Pesticides (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Uso de una composicion para la fabricacion de un medicamento util para prevenir o tratar infecciones virales del tracto respiratorio, en donde la composicion comprende : (a) de 0,01! a 30% en peso de un agente reologico; y (b) de 0,01% a 20% en peso de un agente de in activacion de virus; en donde la composicion tiene una viscosidad de 1 cps a 2.000 cps. Dicho uso en donde el agente reologico se selecciona del grupo formado por carboxipolimetilenos, polímeros carboxivinílicos, homopolímeros de ácido acrílico reticulados con un alil éter de pentaeritritol, homopolímeros de ácido acrílico reticulados con un alil éter de sacarosa, homopolímeros de ácido acrílico reticulados con divinil glicol, polímeros naturales, polímeros derivados de celulosa, polivinilpirrolidonas (PVP), polímeros de dextrano, polímeros de oxido de polietileno, polímeros termorreversibles, polímeros sensibles a iones, copolímeros de polimetil vinil éter y anhídrido maleico, y mezclas de éstos. Dicho uso en donde el agente de inactivacion de virus se selecciona del grupo que comprende un compuesto metálico, un surfactante, un agente quelante, ácido piroglutámico, y mezclas de éstos, en donde el compuesto metálico se selecciona del grupo que comprende salicilatos, fumaratos, benzoatos, glutaratos, lactatos, citratos, malonatos, acetatos, glicolatos, tiosalicilatos, adipatos, succionatos, gluconatos, aspartatos, glicinatos, tartratos, malatos, maleatos, ascorbatos, cloruros, sulfatos, nitratos, fosfatos, fluoruros, yoduros, pidolatos, y mezclas de éstos.
ARP050104576A 2004-11-02 2005-11-01 Metodos para atrapar, inactivar y eliminar infecciones virales mediante la administracion de composiciones para el tracto respiratorio AR052784A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US10/979,498 US20050232868A1 (en) 1999-10-19 2004-11-02 Methods of entrapping, inactivating, and removing viral infections by the administration of respiratory tract compositions

Publications (1)

Publication Number Publication Date
AR052784A1 true AR052784A1 (es) 2007-04-04

Family

ID=36319812

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP050104576A AR052784A1 (es) 2004-11-02 2005-11-01 Metodos para atrapar, inactivar y eliminar infecciones virales mediante la administracion de composiciones para el tracto respiratorio

Country Status (9)

Country Link
US (1) US20050232868A1 (es)
EP (1) EP1809304A2 (es)
JP (1) JP2008519037A (es)
CN (1) CN101052407A (es)
AR (1) AR052784A1 (es)
AU (1) AU2005302032B2 (es)
BR (1) BRPI0517934A (es)
CA (1) CA2586039A1 (es)
WO (1) WO2006050489A2 (es)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10318526A1 (de) * 2003-04-24 2004-11-11 Beiersdorf Ag Reinigungsemulsion mit hohem Fettgehalt
EP1830638A2 (en) * 2004-12-09 2007-09-12 The Dial Corporation Compositions having a high antiviral and antibacterial efficacy
CN101384171A (zh) * 2004-12-09 2009-03-11 日晷公司 具有高抗病毒和抗菌效力的组合物
US20090012174A1 (en) * 2004-12-09 2009-01-08 The Dial Corporation Compositions Having a High Antiviral and Antibacterial Efficacy
MX2007006863A (es) * 2004-12-09 2008-02-25 Dial Corp Composiciones que tienen alta eficacia antiviral y antibacterial.
WO2006062897A2 (en) * 2004-12-09 2006-06-15 The Dial Corporation Compositions having a high antiviral and antibacterial efficacy
US8551917B2 (en) 2005-11-07 2013-10-08 Los Alamos National Security, Llc Use of prolines for improving growth and/or yield
MX2008015088A (es) * 2006-05-26 2009-03-05 Dial Corp Metodo para inhibir la transmision de virus.
MX2008015188A (es) * 2006-05-30 2009-03-06 Dial Corp Composiciones que tienen una alta eficiencia antiviral.
RU2431961C2 (ru) 2006-06-02 2011-10-27 Дзе Дайл Корпорейшн Способ ингибирования переноса вируса гриппа
RU2008152442A (ru) * 2006-06-05 2010-07-20 Дзей Дайл Корпорейшн (Us) Способы и изделия, имеющие высокую противовирусную и противобактериальную эффективность
GB2447012B (en) 2007-02-21 2011-03-16 Pharmacure Health Care Ab Composition for combating epistaxis
WO2009092387A2 (en) * 2008-01-22 2009-07-30 Hegiziy Ashraf Abd Elaziz Mahm Pharmaceutical composition containing a garlic extract
DE202010012255U1 (de) * 2010-09-07 2010-11-18 Krewel Meuselbach Gmbh Nasenspray
AT13384U1 (de) * 2012-12-14 2013-11-15 Fritsch Florian Mag Nahrungsergänzungsmittel
US9290443B2 (en) 2013-03-14 2016-03-22 Los Alamos National Security, Llc Preparation of 4-amino-2,4-dioxobutanoic acid
US9290442B2 (en) 2013-03-14 2016-03-22 Los Alamos National Security, Llc Preparation of 4-amino-2,4-dioxobutanoic acid
US9045392B2 (en) 2013-03-14 2015-06-02 Los Alamos National Security, Llc Preparation of 4-amino-2,4-dioxobutanoic acid
EP2985019B1 (en) * 2014-08-16 2021-10-20 Church & Dwight Co., Inc. Nasal composition having anti-viral properties
EP2985027B1 (en) 2014-08-16 2021-03-31 Church & Dwight Co., Inc. Nasal composition comprising mixture of hyaluronic acids and saline solution
US9963423B2 (en) 2016-01-12 2018-05-08 Millennium Enterprises, Inc. Synthesis of 4-amino-2, 4-dioxobutanoic acid
WO2017212422A1 (en) * 2016-06-08 2017-12-14 Novartis Consumer Health Sa Topical compositions comprising carbomer for the treatment and prevention of viral infections and allergic conditions
US20190076335A1 (en) * 2017-09-12 2019-03-14 IntraMont Technologies, Inc. Oral-surface administered preparation for the prevention of illnesses acquired via the oral cavity and the pharynx
WO2020124277A1 (es) * 2018-12-18 2020-06-25 Copper Andino S.A. Composicion de una formula en spray para controlar mastistis en bovinos
US20220031739A1 (en) * 2020-07-31 2022-02-03 Eye Therapies Llc Anti-viral compositions and methods of use thereof
TR202019326A2 (tr) 2020-11-30 2021-04-21 Haci Murat Mertoglu Ph değeri̇ sayesi̇nde anti̇vi̇ral etki̇ gösteren burun solüsyonu
WO2022147585A1 (en) * 2020-12-31 2022-07-07 Ntby Moss Llc Formulations of a prophylactic nasal spray and methods of use and manufacture thereof

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3958033A (en) * 1974-01-18 1976-05-18 General Foods Corporation Shelf stable emulsions
US4020183A (en) * 1974-12-03 1977-04-26 Ortho Pharmaceutical Corporation Nonionic surface active anti-herpes simplex viral agents
IL58009A (en) * 1978-08-14 1982-11-30 Sterling Drug Inc Process and compositions comprising glutaric acid for neutralizing or destroying viruses
US4523589A (en) * 1983-06-29 1985-06-18 Krauser Robert S Method and apparatus for treating ailments
JPS6160620A (ja) * 1984-09-03 1986-03-28 Teijin Ltd ピログルタミン酸エステル類を含有する医薬品組成物
NO178843C (no) * 1988-07-11 1996-06-19 Sspl Sa Safe Sex Prod Licens Fremgangsmåte for fremstilling av et farmasöytisk preparat for å forhindre seksuelt overförbare sykdommer
US5158761A (en) * 1989-04-05 1992-10-27 Toko Yakuhin Kogyo Kabushiki Kaisha Spray gel base and spray gel preparation using thereof
US6042838A (en) * 1991-02-15 2000-03-28 Uab Research Foundation immunogenic compositions for mucosal administration of pneumococcal surface protein A (PspA)
IT1250691B (it) * 1991-07-22 1995-04-21 Giancarlo Santus Composizioni terapeutiche per somministrazione intranasale comprendenti ketorolac.
US5466680A (en) * 1992-03-26 1995-11-14 Cytologics, Inc. Method and compositions for enhancing white blood cell functioning on a mucosal or cutaneous surface
US5830487A (en) * 1996-06-05 1998-11-03 The Procter & Gamble Company Anti-viral, anhydrous, and mild skin lotions for application to tissue paper products
US5912007A (en) * 1996-02-29 1999-06-15 Warner-Lambert Company Delivery system for the localized administration of medicaments to the upper respiratory tract and methods for preparing and using same
AU714913B2 (en) * 1996-09-27 2000-01-13 Nastech Pharmaceutical Company, Inc. Intranasal formulations for promoting sleep and method of using the same
US6096291A (en) * 1996-12-27 2000-08-01 Biovector Therapeutics, S.A. Mucosal administration of substances to mammals
JP2001518944A (ja) * 1997-06-04 2001-10-16 ザ、プロクター、エンド、ギャンブル、カンパニー 酸性界面活性剤を含有する抗菌性でマイルドなすすぎ落とし液体洗浄組成物
KR20010013377A (ko) * 1997-06-04 2001-02-26 데이비드 엠 모이어 마일드한 잔류성 항균 조성물
US6080783A (en) * 1998-09-01 2000-06-27 Gum Tech International, Inc. Method and composition for delivering zinc to the nasal membrane
WO2001017556A1 (fr) * 1999-09-07 2001-03-15 Shionogi & Co., Ltd. Préparations vaccinales administrables par les muqueuses
AU1095801A (en) * 1999-10-19 2001-04-30 Procter & Gamble Company, The Antimicrobial compositions comprising a biologically active organic acid
WO2001028340A2 (en) * 1999-10-19 2001-04-26 The Procter & Gamble Company Antimicrobial compositions comprising a dicarboxylic acid and a metal salt
CN1379667A (zh) * 1999-10-19 2002-11-13 宝洁公司 预防和治疗感冒和流感样症状的组合物和它们的使用方法
US20040033260A1 (en) * 1999-10-19 2004-02-19 The Procter & Gamble Company Compositions for prevention and treatment of cold and influenza-like symptoms comprising chelated zinc
CA2386936C (en) * 1999-10-19 2007-09-25 The Procter & Gamble Company Antiviral compositions for tissue paper
CA2394612A1 (en) * 2000-01-20 2001-07-26 The Procter & Gamble Company Antimicrobial compositions
US6787164B2 (en) * 2000-02-23 2004-09-07 Bioselect Innovations, Inc. Composition and method for treating the effects of diseases and maladies
CA2451839C (en) * 2001-06-22 2013-08-06 Bentley Pharmaceuticals, Inc. Pharmaceutical compositions comprising peptides and permeation enhancers
ES2342935T3 (es) * 2003-01-13 2010-07-19 THE PROCTER & GAMBLE COMPANY Composiciones para prevencion y tratamiento de sintomas de tipo resfriado y gripe que comprenden polimeros mucoadhesivos seleccionados.

Also Published As

Publication number Publication date
AU2005302032B2 (en) 2011-11-17
WO2006050489A2 (en) 2006-05-11
WO2006050489A3 (en) 2006-11-16
BRPI0517934A (pt) 2008-10-21
AU2005302032A1 (en) 2006-05-11
US20050232868A1 (en) 2005-10-20
EP1809304A2 (en) 2007-07-25
CA2586039A1 (en) 2006-05-11
JP2008519037A (ja) 2008-06-05
CN101052407A (zh) 2007-10-10

Similar Documents

Publication Publication Date Title
AR052784A1 (es) Metodos para atrapar, inactivar y eliminar infecciones virales mediante la administracion de composiciones para el tracto respiratorio
ES2513090T3 (es) Agente de lavado para vajilla a máquina
MXPA02012443A (es) Profarmaco en 3'' de 2'-desoxi-beta-l-nucleosidos.
ES2162319T3 (es) Uso del agente quelante clioquinol para la fabricacion de una composicion farmaceutica para el tratamiento de la enfermedad de alzheimer.
CO5700797A2 (es) Composicion de farmaco conjugado
ATE512976T1 (de) Hemmer des hepatitis-c-virus
BR9406979A (pt) Composto,composicão farmaceutica para tratar uma doenca inflamatória suscetivel de tratamento com um agente anti- inflamatório nao esteroidal processos para tratar uma doenca inflamatória e para preparar um composto sal famacéuticamente aceitável uso de um composto composicão farmaceutica anti-inflamatória nao esteroidal
EA200001030A1 (ru) Получение капсул и таблеток быстрорастворяющегося эфавиренза с использованием супердезинтеграторов
UY26391A1 (es) Inhibidores sglt2 de glucosidos de c-arilo y metodo
UY27329A1 (es) Champues con alcohol de behenilo
EA200601467A1 (ru) Макроциклические соединения в качестве ингибиторов вирусной репликации
RU2002113092A (ru) Композиции для профилактики и лечения простудных и гриппоподобных симптомов и способы их применения
BR0010575A (pt) Composição de amaciamento de tecido, e, método de depositar um agente de amaciamento de tecido não iÈnico no tecido de uma composição de amaciamento de tecido
UA93004C2 (ru) Композиция для вагинального применения
BR0015992A (pt) Compostos, utilização dos mesmos, e, associações terapêuticas
AP2002002674A0 (en) Clear Aqueous Anaesthetic composition.
ES2121000T3 (es) Composicion utilizada como agente terapeutico contra enfermedades hepaticas virales cronicas.
CO5590913A2 (es) Terapia de combinacion antivirica
ES466774A1 (es) Procedimiento para la obtencion de homo- o copolimeros hi- drosolubles de efecto antitumoral
MD20190018A2 (ro) Compoziţie, în particular o compoziţie farmaceutică preventivă şi curativă pe bază de peroxometalat
PA8540501A1 (es) Conjugados peg de hgf-nk4
DK1328276T3 (da) Anvendelse af antiprogestiner til profylakse og behandling af hormonafhængige sygdomme
SE0102055D0 (sv) New Compounds
FR3042484B1 (fr) Compositions generatrice d'oxygene comprenant le (fe, mg)o traite thermiquement
EA200201044A1 (ru) Фармацевтическая композиция с контролируемым высвобождением, содержащая мидодрин и/или десглимидодрин

Legal Events

Date Code Title Description
FB Suspension of granting procedure